Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2018-02-27

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.17m11597PMID 29489077PMCID PMC6013272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.

  2017cited by this paper
• Changes in interleukin‐6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression

  2017cited by this paper
• Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression.

  2017cited by this paper
• The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders

  2016cited by this paper
• Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression

  2016cited by this paper
• Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.

  2016cited by this paper
• Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression.

  2016cited by this paper
• Preexisting mild sleep disturbance as a vulnerability factor for inflammation-induced depressed mood: a human experimental study

  2016cited by this paper
• Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.

  2015cited by this paper
• The role of inflammation in depression: from evolutionary imperative to modern treatment target

  2015cited by this paper
• Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors.

  2015cited by this paper
• Sex Differences in Depressive and Socioemotional Responses to an Inflammatory Challenge: Implications for Sex Differences in Depression

  2015cited by this paper
• Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder

  2015cited by this paper
• Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?

  2015cited by this paper
• Depression as a microglial disease.

  2015cited by this paper
• An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.

  2014cited by this paper
• Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs

  2014cited by this paper
• The Immune System and Electroconvulsive Therapy for Depression

  2014cited by this paper
• Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features.

  2014cited by this paper
• Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)

  2014cited by this paper
• A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

  2013cited by this paper
• Temporal Stability of Serum Concentrations of Cytokines and Soluble Receptors Measured Across Two Years in Low-Risk HIV-Seronegative Men

  2013cited by this paper
• Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.

  2012cited by this paper
• Treatment response and cognitive impairment in major depression: association with C-reactive protein.

  2012cited by this paper
• Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder.

  2011cited by this paper
• Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood.

  2010cited by this paper
• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward.

  2010cited by this paper
• Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

  2008cited by this paper
• Serum markers of brain-cell damage and C-reactive protein are unaffected by electroconvulsive therapy

  2008cited by this paper
• Increase in Plasma Proinflammatory Cytokines After Electroconvulsive Therapy in Patients With Depressive Disorder

  2008cited by this paper
• Electroconvulsive therapy for depression.

  2007cited by this paper
• Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes.

  2005cited by this paper
• Raised Plasma Levels of Tumor Necrosis Factor &agr; in Patients With Depression: Normalization During Electroconvulsive Therapy

  2003cited by this paper
• Paroxetine for the prevention of depression induced by high-dose interferon alfa.

  2001cited by this paper
• Cytokine-associated emotional and cognitive disturbances in humans.

  2001cited by this paper
• Cytokine Production and Treatment Response in Major Depressive Disorder

  2000cited by this paper
• The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

  1998cited by this paper
• Endotoxin produces a depressive-like episode in rats.

  1996cited by this paper
• Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

  1987cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper

• Electroconvulsive therapy for obsessive-compulsive disorder: clinical efficacy and predictive role of inflammatory markers

  2026cites this paper
• Postictal agitation is associated with brain-wide postictal microstructural changes after electroconvulsive therapy-induced seizures.

  2026cites this paper
• Moderators of treatment response in late-life depression.

  2026cites this paper
• CD4+ T cell dysregulation in major depressive disorder is associated with sleep disturbance

  2026cites this paper
• Electroconvulsive Therapy Changes Peripheral Blood Neurotrophic and Inflammatory Markers in Depressed Patients.

  2025cites this paper
• Advancing an Inflammatory Subtype of Major Depression.

  2025cites this paper
• Insomnia and Inflammation Conspire to Heighten Depression Risk: Implications for Treatment and Prevention of Mood Disorders.

  2025cites this paper
• Increased Interleukin-6 Levels in Responders with Treatment-Resistant Depression After Bright Light Therapy

  2025cites this paper
• Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges

  2025cites this paper
• The effects of a 12-week moderate-intensity continuous training intervention on depression, anxiety, and stress in sedentary female college students: a focus on negative emotion regulation

  2025cites this paper
• The Role of Interleukin-8 (IL-8) in Treatment-Resistant Depression: A Review of Mechanisms, Biomarker Potential, and Therapeutic Implications

  2025influential citation
• New insights into the mechanisms of electroconvulsive therapy in treatment-resistant depression

  2025cites this paper
• The Role of Neuroinflammation and Inflammatory Biomarkers in Major Depressive Disorder

  2025influential citation
• Brain structural changes underlying clinical symptom improvement following fast-acting treatments in treatment resistant depression.

  2024cites this paper
• Understanding immune system dysfunction and its context in mood disorders: psychoneuroimmunoendocrinology and clinical interventions

  2024cites this paper
• Trajectory of peripheral inflammation during index ECT in association with clinical outcomes in treatment-resistant depression

  2024cites this paper
• ECT & CRP, quo vadis? - A retrospective study of low-grade inflammation in patients with depression undergoing electroconvulsive therapy

  2024cites this paper
• Association of the neutrophil-to-platelet ratio with response to electroconvulsive therapy in adolescents with major depressive disorder

  2024cites this paper
• Effects of electroconvulsive therapy on inflammatory markers and depressive symptoms in adolescents with major depressive disorder

  2024cites this paper
• Association between rTMS-induced changes in inflammatory markers and improvement in psychiatric diseases: a systematic review

  2024cites this paper
• Predictors of Response to Electroconvulsive Therapy in Major Depressive Disorder: A Review of Recent Research Findings

  2024influential citation
• Continuous theta burst stimulation for bipolar depression: A multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites.

  2024cites this paper
• A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response

  2024cites this paper
• Sex Differences in the Antidepressant and Neurocognitive Effects of Nonconvulsive Electrotherapy in Patients with Treatment-Refractory Depression

  2024influential citation
• Unravelling the secrets of fenugreek through integrated "omics" approach: Challenges and opportunities

  2024cites this paper
• Structural brain plasticity and inflammation are independently related to changes in depressive symptoms six months after an index ECT course.

  2023cites this paper
• Inflammation and Late-Life Depression: Unraveling the Complex Relationship and Potential Therapeutic Strategies.

  2023cites this paper
• Behavioral and transcriptional effects of repeated electroconvulsive seizures in the neonatal MK-801-treated rat model of schizophrenia

  2023cites this paper
• Cytokines as Predictors of Response to Electroconvulsive Therapy: an Update

  2023cites this paper
• Mechanism of Action of ECT in Depression.

  2023cites this paper
• Fenugreek Seed Ethanolic Extract Improves Alveolar Bone Parameters by Attenuating Inflammation in Ovariectomized Rats

  2023cites this paper
• White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD.

  2023cites this paper
• Folate and Its Significance in Depressive Disorders and Suicidality: A Comprehensive Narrative Review

  2023cites this paper
• New and emerging approaches to treat psychiatric disorders

  2023cites this paper
• Multiomics and blood-based biomarkers of electroconvulsive therapy in severe and treatment-resistant depression: study protocol of the DetECT study

  2023cites this paper
• Reviewing the neurobiology of electroconvulsive therapy on a micro- meso- and macro-level.

  2023cites this paper
• Association of plasma cytokines and antidepressant response following mild-intensity whole-body hyperthermia in major depressive disorder

  2023cites this paper
• The Strategy of Targeting Peroxisome Proliferator-Activated Receptor (PPAR) in the Treatment of Neuropsychiatric Disorders.

  2023cites this paper
• Increased Inflammation and Treatment of Depression: From Resistance to Reuse, Repurposing, and Redesign.

  2023cites this paper
• Neuronal-Microglial Liver X receptor β Activating Decrease Neuroinflammation and Chronic Stress-induced Depression-Related Behavior in Mice.

  2022cites this paper
• The effects of electric fields on the mechanical properties and microstructure of ex vivo porcine brain tissues.

  2022cites this paper
• P2X7 Receptor-Related Genetic Mouse Models – Tools for Translational Research in Psychiatry

  2022cites this paper
• Longitudinal trajectory of response to electroconvulsive therapy associated with transient immune response & white matter alteration post-stimulation

  2022cites this paper
• Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a tribute to Bruce McEwen

  2022cites this paper
• Peripheral blood inflammatory markers in depression: Response to electroconvulsive therapy and relationship with cognitive performance.

  2022cites this paper
• Prognostic Significance of Blood-Based Baseline Biomarkers in Treatment-Resistant Depression: A Literature Review of Available Studies on Treatment Response

  2022influential citation
• Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy

  2022cites this paper
• Resolution of depression: antidepressant actions of resolvins.

  2022cites this paper
• Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression

  2022cites this paper
• Peripheral inflammatory effects of different interventions for treatment-resistant depression: A systematic review

  2022cites this paper
• The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside.

  2022cites this paper
• How does IL-6 change after combined treatment in MDD patients? A systematic review

  2022cites this paper
• Journal Pre-proof Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a

  2022cites this paper
• Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis.

  2021cites this paper
• Correlation between Post-Acute Electroconvulsive Therapy Alpha-Band Spectrum Power Increase and Improvement of Psychiatric Symptoms

  2021cites this paper
• Parsing the Network Mechanisms of Electroconvulsive Therapy.

  2021cites this paper
• Molecular Biomarkers of Electroconvulsive Therapy Effects and Clinical Response: Understanding the Present to Shape the Future

  2021cites this paper
• High neutrophil-lymphocyte ratio upon admission is associated with better response in psychotic depression.

  2021cites this paper
• The Pattern of Change in Depressive Symptoms and Inflammatory Markers After Electroconvulsive Therapy

  2021cites this paper
• Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications

  2021cites this paper
• Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression.

  2021cites this paper
• Clinical Implications of Cancer Related Inflammation and Depression: A Critical Review

  2021cites this paper
• Suicide: An Immunological Disorder?

  2021cites this paper
• IL-6, sTNF-R2, and CRP in the context of sleep, circadian preference, and health in adolescents with eveningness chronotype: Cross-sectional and longitudinal treatment effects.

  2021cites this paper
• Inflammatory Markers May Inform the Effects of Electroconvulsive Therapy on Cognition in Patients with Depression

  2021cites this paper
• Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)

  2021cites this paper
• The pattern of inflammatory markers during electroconvulsive therapy in older depressed patients

  2021influential citation
• Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers

  2021cites this paper
• Improvement of psychomotor retardation after electroconvulsive therapy is related to decreased IL-6 levels.

  2020cites this paper
• Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review

  2020cites this paper
• Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid

  2020cites this paper
• Role of interleukin 8 in depression and other psychiatric disorders.

  2020cites this paper
• Differential Effects of Electroconvulsive Therapy in the Treatment of Major Depressive Disorder

  2020cites this paper
• Role of Interleukin-6 in Depressive Disorder

  2020cites this paper
• The effect of electroconvulsive therapy on hematologic inflammatory markers in schizophrenia in association with type of antipsychotic medication

  2020cites this paper
• The cytokine network in the pathogenesis of major depressive disorder. Close to translation?

  2020cites this paper
• Predicting the course of anxiety disorders: The role of biological parameters.

  2020cites this paper
• Inflammation, Hippocampal Volume, and Therapeutic Outcome following Electroconvulsive Therapy in Depressive Patients: A Pilot Study

  2020cites this paper
• Effects of Electroconvulsive Therapy on Depression and Its Potential Mechanism

  2020cites this paper
• Changes in inflammation are related to depression and amount of aerobic exercise in first episode schizophrenia

  2020cites this paper
• Novel Neuroimmunologic Therapeutics in Depression: A Clinical Perspective on What We Know So Far.

  2020cites this paper
• Motivation and sensitivity to monetary reward in late-life insomnia: moderating role of sex and the inflammatory marker CRP

  2020cites this paper
• Inflammation and Depression Treatment Response to Electroconvulsive Therapy: Sex-Specific Role of Interleukin-8.

  2020cites this paper
• Peripheral Biomarkers of Inflammation in Depression: Evidence from Animal Models and Clinical Studies.

  2019cites this paper
• Variations in Hippocampal White Matter Diffusivity Differentiate Response to Electroconvulsive Therapy in Major Depression.

  2019cites this paper
• Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study.

  2019cites this paper
• Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study✰.

  2019cites this paper
• The influence of inflammation on sleep, circadian functioning, and risk among adolescents with an evening circadian preference

  2019cites this paper
• Psychiatric Disorders: Methods and Protocols

  2019cites this paper
• Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review.

  2019cites this paper
• Moderators for depressed mood and systemic and transcriptional inflammatory responses: a randomized controlled trial of endotoxin

  2018cites this paper
• The Molecular Intersection Between Senescence and Major Depression in the Elderly.

  2018cites this paper